Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Healthcare Times Denmark.
Carotenoids Market: Rising Demand for Natural Ingredients and Wellness Products Fuels Global Growth
GlobeNewswire, Inc.
·
July 1, 2025
Boston, July 01, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, “The Global Market for Carotenoids” is expected to grow from $2.1 billion in 2024 to $2.9 billion by the end of 2029 at a compound annual growth rate (CAGR)...
First Clinical Results from MAGiC Catheter Study Published in the Journal of Interventional Cardiac Electrophysiology
GlobeNewswire, Inc.
·
July 1, 2025
ST. LOUIS, July 01, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced the publication of initial clinical results using the MAGiC...
Total number of shares and voting rights in Zealand Pharma as of June 30, 2025
GlobeNewswire, Inc.
·
June 30, 2025
Company announcement – No. 16 / 2025 Total number of shares and voting rights in Zealand Pharma as of June 30, 2025 Copenhagen, Denmark, June 30, 2025 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a...
Health and Wellness Market Size Worth USD 11 Trillion by 2034
GlobeNewswire, Inc.
·
June 24, 2025
Ottawa, June 24, 2025 (GLOBE NEWSWIRE) -- According to Precedence Research, the global health and wellness market size valued at USD 6.87 trillion in 2025 and is projected to reach USD 11 trillion by 2034, growing at a CAGR of 5.40% from 2025 to...
Fertility Attorney and Advocate Rijon Charne Delivers Powerful TEDx Talk on Reproductive Rights and Healthcare Access
EIN Presswire
·
June 26, 2025
Rijon Charne took the TEDx stage in San Diego to deliver a talk titled “Redefining the F Word: Why Fertility Is a Right, Not a Privilege.” SAN DIEGO, CA, UNITED STATES, June 26, 2025 /EINPresswire.com/ -- Nationally recognized fertility attorney...
Evaxion announces changes to Executive Management to optimize the value of proprietary AI-Immunology™ platform and portfolio
GlobeNewswire, Inc.
·
July 1, 2025
Chief Executive Officer (CEO) Christian Kanstrup steps down Chief Scientific Officer Birgitte Rønø appointed interim CEO and search for new CEO has commenced Thomas Schmidt appointed permanent Chief Financial Officer COPENHAGEN, Denmark, July 1,...
Genmab Announces Changes to its Executive Committee
GlobeNewswire, Inc.
·
July 1, 2025
Media Release COPENHAGEN, Denmark; July 1, 2025 Birgitte Stephensen, Executive Vice President and Chief Legal Officer to retire after 23 years with Genmab A/S Greg Mueller joins as new Executive Vice President, General Counsel and Chief Legal...
ReproNovo Announces First Participant Included in U.S. Phase 2 Trial of RPN-001 for Male Infertility
GlobeNewswire, Inc.
·
July 1, 2025
RPN-001 is a novel orally administered aromatase inhibitor being developed for the treatment of infertility in men with low serum testosterone No FDA-approved oral therapies currently exist for this underserved population LAUSANNE, Switzerland and...
Zealand Pharma announces positive topline results from 28-week Phase 1b trial with GLP-1/GLP-2 receptor dual agonist dapiglutide
GlobeNewswire, Inc.
·
June 18, 2025
Company announcement – No. 15 / 2025 Zealand Pharma announces positive topline results from 28-week Phase 1b trial with GLP-1/GLP-2 receptor dual agonist dapiglutide Body weight reductions of a mean of 11.6% after 28 weeks with dapiglutide...
ISS signs new global contract with VELUX Group
GlobeNewswire, Inc.
·
July 1, 2025
Copenhagen , July 01, 2025 (GLOBE NEWSWIRE) -- Under the new contract, ISS will deliver integrated facility services across sites in 12 countries in Northern and Central Europe. These include a wide range of services such as cleaning, waste...
Evosep Joins P4ML to Power World’s Largest Multi-Omic Human Health Study of Two Million Samples
GlobeNewswire, Inc.
·
June 17, 2025
SAINT-MALO, France, June 17, 2025 (GLOBE NEWSWIRE) -- Evosep®, a global leader in robust, high-throughput proteomics technologies, has been selected as the proteomics platform provider for the P4ML - OMIC-Assist Study—the world’s largest...
Beef Market Size Projected to Reach USD 845.97 Bn By 2034
GlobeNewswire, Inc.
·
July 1, 2025
Ottawa, July 01, 2025 (GLOBE NEWSWIRE) -- The global beef market size was calculated at USD 555.28 billion in 2024 and is expected to rise from USD 579.16 billion in 2025 to nearly USD 845.97 billion by 2034, growing at a CAGR of 4.30% over the...
ePharmacy Market Is Booming So Rapidly | BestKenko, Healthkart, PharmEasy
EIN Presswire
·
June 16, 2025
The Global ePharmacy Market is projected to grow from $98.5 Billion in 2025 to $460.8 Billion by 2034, at a CAGR of 18.7%. HYDERABAD, TELANGANA, INDIA, June 16, 2025 /EINPresswire.com/ -- The latest study released on the Global ePharmacy Market...
Disposable Ostomy Bags Market: Discovering the Next Major Healthcare Innovation
GlobeNewswire, Inc.
·
June 16, 2025
Boston, June 16, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, the “Disposable Ostomy Bags: Global Market” is projected to increase from $2.8 billion in 2024 to $3.7 billion by the end of 2031, at a compound annual...
ISS further renews and expands public healthcare contract in Southeast Asia
GlobeNewswire, Inc.
·
June 16, 2025
Copenhagen , June 16, 2025 (GLOBE NEWSWIRE) -- Under the contract, which commences in July 2025, ISS will deliver services across a range of public healthcare institutions. The contract forms part of a larger tender from which ISS has already...
SNIPR BIOME Announces First Patient Dosed in its Phase 1b Clinical Trial of SNIPR001 in Patients with Hematological Cancer
GlobeNewswire, Inc.
·
June 12, 2025
COPENHAGEN, Denmark, June 12, 2025 (GLOBE NEWSWIRE) -- SNIPR Biome ApS (“SNIPR”), the company pioneering the development of precision medicines using CRISPR technology for microbial gene therapy, today announced that the first patient has been...
Allarity Therapeutics Receives Australian Patent Acceptance Notice for Stenoparib DRP® Companion Diagnostic
GlobeNewswire, Inc.
·
June 30, 2025
TARPON SPRINGS, Fla., June 30, 2025 -- Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib—a differentiated, dual PARP and WNT pathway...
NetraMark Founder Coauthors New Publication on AI/ML Use in Clinical Trials, Alongside Authors From Leading Global Regulatory Organizations
GlobeNewswire, Inc.
·
June 12, 2025
TORONTO, June 12, 2025 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0), an artificial intelligence (AI) solutions company transforming clinical trial design in the...
Carolinas MGMA Hosts Inaugural Spring Conference, Unites Healthcare Leaders Across the Carolinas
EIN Presswire
·
June 11, 2025
Carolinas Medical Group Management Association marked a significant milestone with its inaugural Spring Conference at the Wilmington Convention Center. WILMINGTON, NC, UNITED STATES, June 11, 2025 /EINPresswire.com/ -- Carolinas Medical Group...
Enterome raises $19 million to fund clinical development of its OncoMimics™ immunotherapy to treat Follicular Lymphoma
GlobeNewswire, Inc.
·
June 12, 2025
Proceeds to fund Phase 1/2 trial of EO2463 OncoMimics™, as a monotherapy or in combination, to treat multiple forms of indolent non-Hodgkin lymphoma (iNHL) $9 million from new investor The Institute for Follicular Lymphoma Innovation (IFLI) $10...